CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,727 | $196.07 | $535K | 1,514,658 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,385 | $197.55 | $274K | 1,513,273 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,392 | $198.43 | $673K | 1,509,881 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,945 | $199.22 | $587K | 1,506,936 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −4,159 | $200.41 | $834K | 1,502,777 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,895 | $201.52 | $382K | 1,500,882 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,957 | $195.16 | $772K | 1,583,305 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −6,458 | $195.72 | $1.3M | 1,576,847 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,696 | $197.04 | $334K | 1,575,151 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,086 | $198.08 | $413K | 1,573,065 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −4,008 | $198.93 | $797K | 1,569,057 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,600 | $200.15 | $721K | 1,565,457 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,395 | $200.98 | $481K | 1,563,062 |
| 2024-09-12 | Krishnan Suma President, R&D | Sale 10b5-1 | −800 | $201.81 | $161K | 1,562,262 |
| 2024-09-12 | Krishnan Krish S President and CEO | Sale 10b5-1 | −3,957 | $195.16 | $772K | 1,583,305 |
| 2024-09-12 | Krishnan Krish S President and CEO | Sale 10b5-1 | −6,458 | $195.72 | $1.3M | 1,576,847 |
| 2024-09-12 | Krishnan Krish S President and CEO | Sale 10b5-1 | −1,696 | $197.04 | $334K | 1,575,151 |
| 2024-09-12 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,086 | $198.08 | $413K | 1,573,065 |
| 2024-09-12 | Krishnan Krish S President and CEO | Sale 10b5-1 | −4,008 | $198.93 | $797K | 1,569,057 |
| 2024-09-12 | Krishnan Krish S President and CEO | Sale 10b5-1 | −3,600 | $200.15 | $721K | 1,565,457 |
Page 18 of 42 · 828 trades